Fig. 1From: Vasodilator-stimulated phosphoprotein-guided Clopidogrel maintenance therapy reduces cardiovascular events in atrial fibrillation patients requiring anticoagulation therapy and scheduled for percutaneous coronary intervention: a prospective cohort studyStudy flowchart and follow-up. AF: atrial fibrillation; CCr: creatinine clearance rate; NYHA: New York Heart Association; PCI: percutaneous coronary intervention; VASP: vasodilator-stimulated phosphoproteinBack to article page